FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop LET Gel Recall

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0

Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop · Irving, TX

Risk level
Class III
Reported by FDA
Dec 13, 2023
Recall ID
D-0140-2024
Check your lot numberHow we source this data

Summary

Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop recalled LET Gel starting Nov 9, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0140-2024 on Dec 13, 2023. Reason: Product Mix-up: Incorrect Product Formulation. Status: Terminated.

Why it was recalled

Product Mix-up: Incorrect Product Formulation

Product description

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

Lot numbers, UPCs & expiration codes

Lot#: 09202023@7, Exp 03/18/2024

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0140-2024
Classification
Class III
Status
Terminated
Recall initiated
Nov 9, 2023
FDA report date
Dec 13, 2023
Quantity
190 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop

Original FDA data

Every field from FDA enforcement report D-0140-2024, exactly as published.

Show all FDA fields
City
Irving
State
TX
Status
Terminated
Country
United States
Event ID
93316
Address
8400 Esters Blvd Ste 190
Code information
Lot#: 09202023@7, Exp 03/18/2024
Postal code
75063-2217
Report date
Dec 13, 2023
Product type
Drugs
Recall number
D-0140-2024
Classification
Class III
Recalling firm
Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop
Product quantity
190 syringes
Termination date
Aug 20, 2024
Reason for recall
Product Mix-up: Incorrect Product Formulation
Voluntary / mandated
Voluntary: Firm initiated
Product description
LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1
Distribution pattern
USA Nationwide
Recall initiation date
Nov 9, 2023
Center classification date
Dec 6, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0140-2024, published Dec 13, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls